Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 3, 2003, Pages 154-158

  Aoki, Taro ^a   Yamazaki, Hiroyuki ^a   Tamaki, Taro ^a   Sato, Fumiyasu ^a   Kitahara, Masaki ^b   Saito, Yasushi ^c  

^a Tokyo New Drug Res Laboratories I   (Japan)

^b NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 Hydroxy 3 methylglutaryl conenzyme A reductase inhibitor; CAS 147526 32 7; Pitavastatin, experimental postprandial lipemia, lipoprotein lipase, microsomal triglyceride transfer protein

Indexed keywords

ATORVASTATIN; CAS 134523 00 5; CAS 147526 32 7; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PITAVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FAT INTAKE; GUINEA PIG; HYPERLIPIDEMIA; LYMPH VESSEL; MALE; NONHUMAN; PROTEIN HYDROLYSIS; PROTEIN SECRETION; SMALL INTESTINE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037232388     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297088     Document Type: Article

References (20)

1. Zilversmit, D. B., A postprandial phenomenon. Circulation 60, 473 (1979)
2. Bae, J. H., Bassenge, E., Lee, H. J. et al., Impact of post-prandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates. Atherosclerosis 158, 165 (2001)
3. Przybycien, K., Kornacewicz-Jach, Z., Torbus-Lisiecka, B. et al., Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol? Coron. Artery Dis. 11, 377 (2000)
4. Coughlan, B. J., Sorrentino, M. J., Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad. Med. 108, 77 (2000)
5. Maron, D. J., Fazio, S., Linton, M. F., Current perspectives on statins. Circulation 101, 207 (2000)
6. Packard, C. J., Effects of drugs on postprandial lipoprotein metabolism. Proc. Nutr. Soc. 56, 745 (1997)
7. Burnett, J. R., Barrett, P. H. Vicini, P., The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler. Thromb. Vasc. Biol. 18, 1906 (1998)
8. Battula, S. B., Fitzsimons, O., Morenom, S., Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Metabolism 49, 1049 (2000)
9. Fujino, H., Kojima, J., Yamada, Y. et al., Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (4): Interspecies variation in laboratory animals and humans. Xenobiot. Metabol. Dispos. 14, 79 (1999)
10. Aoki, T., Nishimura, H., Nakagawa, S., Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneim.-Forsch./Drug Res. 47 (II), 904 (1997)
11. Kajinami, K., Koizumi, J., Ueda, K. et al., Effects of pitavastatin, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Am. J. Cardiol. 85, 178 (2000)
12. Suzuki, H., Aoki, T., Tamaki, T., Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis 146, 259 (1999)
13. Aoki, T., Yoshinaka, Y., Yamazaki, H. et al., Triglyceride-lowering effect of pitavastatin in a rat model of postprandial lipemia. Eur. J. Pharmacol. 444, 107 (2002)
14. Fujioka, T., Nara, F., Tsujita, Y., The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats. Biochim. Biophys. Acta 1254, 7 (1995)
15. Havel, R. J., Eder, H. A., Bradgon, J. H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 56, 1420 (1975)
16. Suzuki, H., Yamazaki, H., Aoki, T., Hypolipidemic effect of NK-104 and other 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in guinea pigs. Arzneim.-Forsch./Drug Res. 51 (I), 38 (2001)
17. Kawamura, M., Gotoda, T., Mori, N. et al., Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies. J. Lipid Res. 35, 1688 (1994)
18. Isusi, E., Aspichueta, P., Liza, M. et al., Short- and long term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes. Atherosclerosis 153, 283 (2000)
19. Conde, K., Roy, S., Freake, H. C. et al., Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guineapig. Lipids 34, 1327 (1999)
20. Cassader, M., Gambino, R., Ruiu, G. et al., Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects. Aging (Milano) 8, 421 (1996)